VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | The evolving treatment of MF, PV, and ET: aiming for clonal elimination

Srdan Verstovsek, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, briefly discusses unanswered questions and the evolving treatment of myelofibrosis (MF), essential thrombocythemia (ET), and polycythemia vera (PV), highlighting the importance of aiming for clonal elimination rather than symptom control. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter